Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7282 p44
17 January 2004

This article
Reprint
Photocopy


News summary

Related websites
Neurology abstract (more)
Journal of Epidemiology and Community Health (jech.bmjjournals.com)


Vitamin D supplements may protect against MS

Women who take vitamin D supplements may have a lower risk of developing multiple sclerosis than women who do not take supplements, according to recent research.

Investigators studied data collected from the US Nurses Health Study and Nurses Health Study II, which involved almost 190,000 women. They looked at the women’s diets and use of multivitamin supplements at baseline and every four years, as well as the levels of 25-hydroxyvitamin D in the women’s blood. Results were adjusted for known MS risk factors such as age, smoking and latitude of residence at birth. Of the 187,563 women included in the study, 173 women developed the disease.

The researchers found that women with the highest intake of vitamin D supplements (at least 400 IU per day) were 40 per cent less likely to develop MS than women who did not use supplements. Women who had a high intake of vitamin D from a combination of food and supplements also had a lower risk of developing MS, but those who had a high intake of vitamin D from diet alone were not found to be any less at risk of developing the disease.

However, the researchers acknowledge that because supplemental vitamin D intake used by women in the study was mainly from multivitamins, the effects of vitamin D can not easily be isolated from the effects of other vitamins in the formulations. Furthermore, they point out the difficulty of separating the contribution of diet and the effects of sunlight on circulating levels of vitamin D.

The researchers suggest that future studies should measure the levels of vitamin D in the blood before the onset of MS, and that it may be important to assess whether supplementation with the vitamin slows the progression of the disease (Neurology 2004;62:60).

Sunlight and MS More data emerged this week to support the association between exposure to sunlight and development of MS. Researchers from the Institute of Health Sciences in Oxford say that a minimum level of exposure to the sun per year may provide protection from the disease. They studied records of people with MS and other neurological disease and found that prevalence of skin cancers associated with prolonged, continuous exposure to sunshine was lower than average in people with MS (Journal of Epidemiology and Community Health 2004; 58:142).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal